Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Kiyoko Nojima"'
Autor:
Sho Miyamoto, Yudai Kuroda, Takayuki Kanno, Akira Ueno, Nozomi Shiwa-Sudo, Naoko Iwata-Yoshikawa, Yusuke Sakai, Noriyo Nagata, Takeshi Arashiro, Akira Ainai, Saya Moriyama, Noriko Kishida, Shinji Watanabe, Kiyoko Nojima, Yohei Seki, Takuo Mizukami, Hideki Hasegawa, Hideki Ebihara, Shuetsu Fukushi, Yoshimasa Takahashi, Ken Maeda, Tadaki Suzuki
Publikováno v:
iScience, Vol 26, Iss 5, Pp 106694- (2023)
Summary: Evaluating the serum cross-neutralization responses after breakthrough infection with various SARS-CoV-2 variants provides valuable insight for developing variant-proof COVID-19 booster vaccines. However, fairly comparing the impact of break
Externí odkaz:
https://doaj.org/article/67f878daf29d4a9d93a13104fc46ab22
Autor:
Hokyung Oh, Jinho Shin, Chung Keel Lee, Masaki Ochiai, Kiyoko Nojima, Chang Kweng Lim, Sanj Raut, Irene Lisovsky, Stella Williams, Ki Young Yoo, Dong-Yeop Shin, Manabu Ato, Qiang Ye, Kiwon Han, Chulhyun Lee, Naery Lee, Ji Young Hong, Kikyung Jung, Pham Van Hung, Jayoung Jeong
Publikováno v:
Osong Public Health and Research Perspectives, Vol 9, Iss 3, Pp 133-139 (2018)
The Second Meeting of the National Control Laboratories for Vaccines and Biologicals in the Western Pacific, was jointly organized by the National Institute of Food and Drug Safety Evaluation of the Ministry of Food and Drug Safety in the Republic of
Externí odkaz:
https://doaj.org/article/74681ecf7b7c4188abaac95ea5a7d272
Autor:
Reiko Shimbashi, Teiichiro Shiino, Akira Ainai, Saya Moriyama, Satoru Arai, Saeko Morino, Sayaka Takanashi, Takeshi Arashiro, Motoi Suzuki, Yukimasa Matsuzawa, Kenichiro Kato, Mitsuru Hasegawa, Rie Koshida, Masami Kitaoka, Takafumi Ueno, Hidefumi Shimizu, Hiroyoshi Yuki, Tomoko Takeda, Fukumi Nakamura-Uchiyama, Kashiya Takasugi, Shun Iida, Tomoe Shimada, Hirofumi Kato, Tsuguto Fujimoto, Naoko Iwata-Yoshikawa, Kaori Sano, Souichi Yamada, Yudai Kuroda, Kazu Okuma, Kiyoko Nojima, Noriyo Nagata, Shuetsu Fukushi, Ken Maeda, Yoshimasa Takahashi, Tadaki Suzuki, Makoto Ohnishi, Keiko Tanaka-Taya
Publikováno v:
Glob Health Med
As coronavirus disease 2019 (COVID-19) outbreaks in healthcare facilities are a serious public health concern, we performed a case-control study to investigate the risk of COVID-19 infection in healthcare workers. We collected data on participants' s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d02985d26c7a9a1c61bcf0f27e02ddbb
https://europepmc.org/articles/PMC9974228/
https://europepmc.org/articles/PMC9974228/
Autor:
Sho Miyamoto, Yudai Kuroda, Takayuki Kanno, Akira Ueno, Nozomi Shiwa-Sudo, Naoko Iwata-Yoshikawa, Yusuke Sakai, Noriyo Nagata, Takeshi Arashiro, Akira Ainai, Saya Moriyama, Noriko Kishida, Shinji Watanabe, Kiyoko Nojima, Yohei Seki, Takuo Mizukami, Hideki Hasegawa, Hideki Ebihara, Shuetsu Fukushi, Yoshimasa Takahashi, Ken Maeda, Tadaki Suzuki
Understanding the differences in serum cross-neutralizing responses against SARS-CoV-2 variants, including Omicron sub-lineages BA.5, BA.2.75, and BQ.1.1, elicited by exposure to distinct antigens is essential for developing COVID-19 booster vaccines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0fbaf72a165adb53fb3cbbe77bcb5a1b
https://doi.org/10.1101/2023.02.08.23285673
https://doi.org/10.1101/2023.02.08.23285673
Autor:
Yohei Seki, Yasuo Yoshihara, Kiyoko Nojima, Haruka Momose, Shuetsu Fukushi, Saya Moriyama, Ayumi Wagatsuma, Narumi Numata, Kyohei Sasaki, Tomoyo Kuzuoka, Yoshiyuki Yato, Yoshimasa Takahashi, Ken Maeda, Tadaki Suzuki, Takuo Mizukami, Isao Hamaguchi
SUMMARYBackgroundThe Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified in Japan in November 2021. This variant contains up to 36 mutations in the spike protein, the target of neutralizing antibodies, and c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf7faa914b7c594808b9fc3ecdc1e1aa
https://doi.org/10.1101/2022.01.20.22269587
https://doi.org/10.1101/2022.01.20.22269587
Autor:
Yohei Seki, Yasuo Yoshihara, Kiyoko Nojima, Haruka Momose, Shuetsu Fukushi, Saya Moriyama, Ayumi Wagatsuma, Narumi Numata, Kyohei Sasaki, Tomoyo Kuzuoka, Yoshiyuki Yato, Yoshimasa Takahashi, Ken Maeda, Tadaki Suzuki, Takuo Mizukami, Isao Hamaguchi
Publikováno v:
Med (New York, N.Y.). 3(6)
The Omicron variant of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) was identified in Japan in November 2021. This variant contains up to 36 mutations in the spike protein, the target of neutralizing antibodies, and can escape vaccine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::598a4e5c20c94966c94a4403f45deee6
https://pubmed.ncbi.nlm.nih.gov/35815933
https://pubmed.ncbi.nlm.nih.gov/35815933
Autor:
Sho Miyamoto, Takeshi Arashiro, Yu Adachi, Saya Moriyama, Hitomi Kinoshita, Takayuki Kanno, Shinji Saito, Harutaka Katano, Shun Iida, Akira Ainai, Ryutaro Kotaki, Souichi Yamada, Yudai Kuroda, Tsukasa Yamamoto, Keita Ishijima, Eun-Sil Park, Yusuke Inoue, Yoshihiro Kaku, Minoru Tobiume, Naoko Iwata-Yoshikawa, Nozomi Shiwa-Sudo, Kenzo Tokunaga, Seiya Ozono, Takuya Hemmi, Akira Ueno, Noriko Kishida, Shinji Watanabe, Kiyoko Nojima, Yohei Seki, Takuo Mizukami, Hideki Hasegawa, Hideki Ebihara, Ken Maeda, Shuetsu Fukushi, Yoshimasa Takahashi, Tadaki Suzuki
SUMMARYBackgroundThe immune profile against SARS-CoV-2 has dramatically diversified due to a complex combination of exposure to vaccines and infection by various lineages/variants, likely generating a heterogeneity in protective immunity in a given p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::068f1763c838eb306ab57a07c97282bc
https://doi.org/10.1101/2021.12.28.21268481
https://doi.org/10.1101/2021.12.28.21268481
Autor:
Takaji Wakita, Tsuguto Fujimoto, Hitomi Kinoshita, Yu Adachi, Masanori Isogawa, Masaharu Shinkai, Saya Moriyama, Takahiro Okai, Tetsuro Matano, Makoto Ohnishi, Keisuke Tonouchi, Souichi Yamada, Shuetsu Fukushi, Lin Sun, Kazutaka Terahara, Shigeki Nakamura, Yudai Kuroda, Ayae Nishiyama, Natsuo Tachikawa, Keita Ishijima, Eun-Sil Park, Ken Maeda, Takayuki Matsumura, Tomohiro Takano, Tadaki Suzuki, Takayuki Kanno, Yoshimasa Takahashi, Kazu Okuma, Ai Kawana-Tachikawa, Takashi Sato, Minoru Tobiume, Kiyoko Nojima, Taishi Onodera
Publikováno v:
Immunity
Antibody titers against SARS-CoV-2 slowly wane over time. Here, we examined how time affects antibody potency. To assess the impact of antibody maturation on durable neutralizing activity against original SARS-CoV-2 and emerging variants of concern (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cfc8b626ed12525fb618686b307a739
https://pubmed.ncbi.nlm.nih.gov/34246326
https://pubmed.ncbi.nlm.nih.gov/34246326
Autor:
Kazu Okuma, Ken Maeda, Shuetsu Fukushi, Tsuguto Fujimoto, Takashi Sato, Keita Ishijima, Tadaki Suzuki, Hitomi Kinoshita, Makoto Ohnishi, Souichi Yamada, Kiyoko Nojima, Takayuki Kanno, Masanori Isogawa, Masaharu Shinkai, Minoru Tobiume, Ayae Nishiyama, Keisuke Tonouchi, Natsuo Tachikawa, Taishi Onodera, Ai Kawana-Tachikawa, Lin Sun, Kazutaka Terahara, Takayuki Matsumura, Tomohiro Takano, Saya Moriayma, Shigeki Nakamura, Takahiro Okai, Tetsuro Matano, Park Eunsil, Yudai Kuroda, Yoshimasa Takahashi, Takaji Wakita, Yu Adachi
Publikováno v:
SSRN Electronic Journal.
SARS-CoV-2 variants have raised concerns regarding resistance to neutralizing antibodies elicited by the parental virus. In the present study, we monitored multiple parameters of neutralizing antibodies in convalescent plasma up to 10 months after th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c51f375d8e4e9a0753153ba8a829332
https://doi.org/10.2139/ssrn.3831465
https://doi.org/10.2139/ssrn.3831465
The 2nd Meeting of National Control Laboratories for Vaccines and Biologicals in the Western Pacific
Autor:
Pham Van Hung, Manabu Ato, Chung Keel Lee, Kiyoko Nojima, Stella C. Williams, Kikyung Jung, Chang Kweng Lim, Dong-Yeop Shin, Hokyung Oh, Qiang Ye, Naery Lee, Irene Lisovsky, Ki Young Yoo, Masaki Ochiai, Jayoung Jeong, Kiwon Han, Ji Young Hong, Jinho Shin, Chulhyun Lee, Sanj Raut
Publikováno v:
Osong Public Health and Research Perspectives
Osong Public Health and Research Perspectives, Vol 9, Iss 3, Pp 133-139 (2018)
Osong Public Health and Research Perspectives, Vol 9, Iss 3, Pp 133-139 (2018)
The Second Meeting of the National Control Laboratories for Vaccines and Biologicals in the Western Pacific, was jointly organized by the National Institute of Food and Drug Safety Evaluation of the Ministry of Food and Drug Safety in the Republic of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19712646d2280031dbd6ec7de1912423
https://doi.org/10.24171/j.phrp.2018.9.3.10
https://doi.org/10.24171/j.phrp.2018.9.3.10